Allied Market Research
Loading...
0
New
New
2021
Australia And New Zealand Fetal Bovine Serum Market

Australia and New Zealand Fetal Bovine Serum Market by Origin (Australia Origin, New Zealand Origin, US Origin, Mexico Origin, and Brazil Origin) by Application (Biopharmaceuticals, Cell Culture, Human & Animal Vaccine Production, and Others), and End User (Biotechnology & Pharmaceutical Industry, Academic Institute, and Research Laboratory): Opportunity Analysis and Industry Forecast, 2021-2030

A13702
Pages: 80
Sep 2021 | 72 Views
   
Author(s) : Swapna Singh, Sanjivan Gill , Onkar Sumant
Tables: 24
Charts: 15
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Australia And New Zealand Fetal Bovine Serum Market

Request Now !

Australia and New Zealand Fetal Bovine Serum Market Overview

The Australia and New Zealand Fetal Bovine Serum market size was valued at $20 million in 2020 and is projected to reach $35 million by 2030, registering a CAGR of 5.2% from 2021 to 2030. Fetal bovine serum (FBS) is the liquid fraction of clotted blood from fetal calves. It is extracted from the blood drawn from a bovine fetus. Fetal bovine serum contains high amount of nutritional and macromolecular factors essential for cell growth. It is used extensively by academic, institutes, clinics, and industrial researchers as a supplement to basal growth medium in cell culture applications. The growth of the market is driven by factors such as increase in funding & investment for R&D activities & innovation in the life science industry, high demand for FBS and rise in advancements associated with biotechnology. In addition, rise in R&D investment, high demand for fetal bovine sera and surge in biopharmaceutical production is anticipated to drive the market growth.

The COVID-19 pandemic has had a varying nature of impact on the fetal bovine serum (FBS) market in Australia and New Zealand for the year 2020 and 2021. For instance, the industries using the fetal bovine serum for human and animal vaccine production saw both negative and positive impact due to the viral outbreak. Furthermore, industries using the serum for biopharmaceuticals saw a positive impact owing to rise in biopharmaceutical research related to COVID-19. Similarly, other industries using FBS were hit in a diverse manner due to the COVID-19 outbreak.

However, High price of fetal bovine serum and increased use of alternatives hamper the growth of the market. Moreover, untapped potential of the emerging economies is great opportunity which will boost the market growth in forecast period.

Australia-and-New-Zealand-Fetal-Bovine-Serum-Market-2021-2030

Get more information on this report : Request Sample Pages

Fetal bovine serum is also used as an additional media supplement for cell culture due to the high content of embryonic growth-promoting factors. The serum is considered one of the most effective growth promoters compared to the other animal-based serums available for most cell culture systems, indicative of an increase in the use of fetal bovine serum, which is expected to fuel the Australia and New Zealand Fetal Bovine Serum Market growth.                 

COVID-19 Impact

Coronavirus (COVID-19) was discovered in December 2019 in Hubei province of Wuhan city in China. The disease is caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted from humans to humans.

After its discovery in Wuhan, the disease rapidly spread to other parts of the globe. Moreover, this virus causes various symptoms in patients, which range from common symptoms to serious symptoms. For instance, common symptoms include fever, dry cough, and fatigue. However, serious symptoms include difficulty in breathing or shortness of breath, chest pain or pressure, and loss of speech or movement. Furthermore, the virus has high potential of lethality in geriatric population. On 11th March 2020, the World Health Organization made an assessment that COVID-19 can be characterized as pandemic. In addition, there are only a few vaccines that received emergency approvals for COVID-19 treatment or prevention. Thus, social distancing is observed as the most important measure to stop the spread of this disease. Furthermore, to maintain social distancing, various countries across the world have adopted nationwide lockdowns.

Almost every nation is dealing with the outbreak. Most markets are experiencing a decline, owing to the outbreak. This also includes the Australia and New Zealand Fetal Bovine Serum market. In addition, the COVID-19 pandemic is expected to have a positive impact on the Australia and New Zealand fetal bovine serum market. Fetal bovine serum has extensively been used in vaccine production and in-vitro cell-culture preparation in healthcare industries. This serum is used as a supplement in the growth media for COVID-19 vaccines and other vaccines. Moreover, during pandemic, due to the high transmission rate and lack of treatment, many countries are suffering due to the impact of the pandemic, and they are continuing to bear a significant burden on both their economies and healthcare systems. Furthermore, COVID-19 outbreak is having a positive impact on the growth of the market.

Application Segment Review

Based on Australia and New Zealand fetal bovine serum market trends by application, the cell culture segment accounted for the majority of the market share in 2020. This is attributed to the fact bovine serum is used majorly as an additional supplement in the cell culture media owing to its property such as presence of growth promoters, antibodies, and others required for cell proliferation and growth. Many key players including Merck KGaA (Sigma Aldrich), Thermo Fischer, and others provide specialty FBS for use in cell culture where the highest standard of product quality and documentation is required.

Australia and New Zealand Fetal Bovine Serum Market
By Application

Your browser does not support the canvas element.

Cell Culture segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

End User Segment Review

By end user, the biotechnology & pharmaceutical company segment generated the maximum revenue in 2020. This segment is anticipated to exhibit prominent growth rate, due to significant rise in R&D for the development of biopharmaceutical drugs and cancer research. Life science and pharmaceutical research involves the use of fetal bovine serum to execute different operations such as bio-production, biopharmaceutical & vaccine production, cancer research, toxicity testing, virology, gene therapy, drug screening, discovery & development, gene therapy, and others.

Australia and New Zealand Fetal Bovine Serum Market
By End User

Your browser does not support the canvas element.

Biotechnology & Pharmaceutical Company segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Key Market Players

  • Atlas Biologicals
  • Biological Industries
  • Bio Techne
  • Biowest
  • GE Healthcare
  • HiMedia Laboratories Pvt. Ltd.
  • Merck KGaA (Sigma Aldrich)
  • Pan Biotech
  • Rocky Mountain Biologicals
  • Thermo Fisher Scientific Inc.

Key Benefits For Stakeholders

  • This report provides a detailed quantitative analysis of the current Australia and New Zealand Fetal Bovine Serum market trends and forecast estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.
  • An in-depth Australia and New Zealand Fetal Bovine Serum Market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
  • The projections in this report are made by analyzing the current trends and future market potential from 2021 to 2030, in terms of value.
  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
  • Key market players within the Australia and New Zealand Fetal Bovine Serum market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the Australia and New Zealand Fetal Bovine Serum market.

Key Market Segments

By Origin

  • Australia Origin
  • New Zealand Origin
  • US Origin
  • Mexico Origin
  • Brazil Origin

By Application

  • Biopharmaceuticals
  • Cell Culture
  • Human and Animal Vaccine Production
  • Others

By End User

  • Biotechnology & Pharmaceutical Industry
  • Academic Institute
  • Research Laboratory
 

CHAPTER 1:  INTRODUCTION

1.1.REPORT DESCRIPTION
1.2.KEY MARKET SEGMENTS
1.3.KEY BENEFITS
1.4.RESEARCH METHODOLOGY

1.4.1.Primary research
1.4.2.Secondary research
1.4.3.Analyst tools and models

CHAPTER 2:  EXECUTIVE SUMMARY

2.1.CXO PERSPECTIVE

CHAPTER 3:  MARKET LANDSCAPE

3.1.MARKET DEFINITION AND SCOPE
3.2.KEY FINDINGS

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.PORTER'S FIVE FORCES ANALYSIS

3.3.1.Bargaining power of suppliers
3.3.2.Threat of new entrants
3.3.3.Threat of substitutes
3.3.4.Competitive rivalry
3.3.5.Bargaining power among buyers

3.4.MARKET DYNAMICS

3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities

3.5.COVID 19 IMPACT ANALYSIS

CHAPTER 4:  AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET BY ORIGIN

4.1.OVERVIEW
4.2. AUSTRALIA ORIGIN

4.2.1.Key market trends, growth factors andopportunities
4.2.2.Market size and forecast,

4.3. NEW ZEALAND ORIGIN

4.3.1.Key market trends, growth factors and opportunities
4.3.2.Market size and forecast,

4.4. US ORIGIN

4.4.1.Key market trends, growth factors and opportunities
4.4.2.Market size and forecast,

4.5. MEXICO ORIGIN

4.5.1.Key market trends, growth factors and opportunities
4.5.2.Market size and forecast,

4.6. BRAZIL ORIGIN

4.6.1.Key market trends, growth factors and opportunities
4.6.2.Market size and forecast,

CHAPTER 5:  AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET BY APPLICATION

5.1.OVERVIEW
5.2. BIOPHARMACEUTICALS

5.2.1.Key market trends, growth factors and opportunities
5.2.2.Market size and forecast,

5.3. CELL CULTURE

5.3.1.Key market trends, growth factors and opportunities
5.3.2.Market size and forecast,

5.4. HUMAN AND ANIMAL VACCINE PRODUCTION

5.4.1.Key market trends, growth factors and opportunities
5.4.2.Market size and forecast,

5.5. OTHERS

5.5.1.Key market trends, growth factors and opportunities
5.5.2.Market size and forecast,

CHAPTER 6:  AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET BY END USER

6.1.OVERVIEW
6.2. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES

6.2.1.Key market trends, growth factors and opportunities
6.2.2.Market size and forecast,
6.2.3.Market size and forecast, by Origin
6.2.4.Market size and forecast, by Therapeutic Type

  6.2.4.1. Gamma Irradiation
  6.2.4.2. Heat Inactivation
  6.2.4.3. Charcoal Stripped
  6.2.4.4. Other

6.3. ACADEMIC INSTITUTE

6.3.1.Key market trends, growth factors and opportunities
6.3.2.Market size and forecast,
6.3.3.Market size and forecast, by Origin
6.3.4.Market size and forecast, by Therapeutic Type

  6.3.4.1. Gamma Irradiation
  6.3.4.2. Heat Inactivation
  6.3.4.3. Charcoal Stripped
  6.3.4.4. Other

6.4. RESEARCH LABORATORY

6.4.1.Key market trends, growth factors and opportunities
6.4.2.Market size and forecast,
6.4.3.Market size and forecast, by Origin
6.4.4.Market size and forecast, by Therapeutic Type

  6.3.4.1. Gamma Irradiation
  6.3.4.2. Heat Inactivation
  6.3.4.3. Charcoal Stripped
  6.3.4.4. Other

CHAPTER 7:  COMPANY PROFILES

7.1. ATLAS BIOLOGICALS

7.1.1.Company overview
7.1.2.Key Executives
7.1.3.Company snapshot
7.1.4.Operating business segments
7.1.5.Product portfolio
7.1.6.Business performance
7.1.7.Key strategic moves and developments

7.2. BIOLOGICAL INDUSTRIES

7.2.1.Company overview
7.2.2.Key Executives
7.2.3.Company snapshot
7.2.4.Operating business segments
7.2.5.Product portfolio
7.2.6.Business performance
7.2.7.Key strategic moves and developments

7.3. BIO TECHNE

7.3.1.Company overview
7.3.2.Key Executives
7.3.3.Company snapshot
7.3.4.Operating business segments
7.3.5.Product portfolio
7.3.6.Business performance
7.3.7.Key strategic moves and developments

7.4. BIOWEST

7.4.1.Company overview
7.4.2.Key Executives
7.4.3.Company snapshot
7.4.4.Operating business segments
7.4.5.Product portfolio
7.4.6.Business performance
7.4.7.Key strategic moves and developments

7.5. GE HEALTHCARE

7.5.1.Company overview
7.5.2.Key Executives
7.5.3.Company snapshot
7.5.4.Operating business segments
7.5.5.Product portfolio
7.5.6.Business performance
7.5.7.Key strategic moves and developments

7.6. HIMEDIA LABORATORIES PVT. LTD.

7.6.1.Company overview
7.6.2.Key Executives
7.6.3.Company snapshot
7.6.4.Operating business segments
7.6.5.Product portfolio
7.6.6.Business performance
7.6.7.Key strategic moves and developments

7.7. MERCK KGAA (SIGMA ALDRICH)

7.7.1.Company overview
7.7.2.Key Executives
7.7.3.Company snapshot
7.7.4.Operating business segments
7.7.5.Product portfolio
7.7.6.Business performance
7.7.7.Key strategic moves and developments

7.8. PAN BIOTECH

7.8.1.Company overview
7.8.2.Key Executives
7.8.3.Company snapshot
7.8.4.Operating business segments
7.8.5.Product portfolio
7.8.6.Business performance
7.8.7.Key strategic moves and developments

7.9. ROCKY MOUNTAIN BIOLOGICALS

7.9.1.Company overview
7.9.2.Key Executives
7.9.3.Company snapshot
7.9.4.Operating business segments
7.9.5.Product portfolio
7.9.6.Business performance
7.9.7.Key strategic moves and developments

7.10. THERMO FISHER SCIENTIFIC INC.

7.10.1.Company overview
7.10.2.Key Executives
7.10.3.Company snapshot
7.10.4.Operating business segments
7.10.5.Product portfolio
7.10.6.Business performance
7.10.7.Key strategic moves and developments

LIST OF TABLES

TABLE 1. AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET, BY ORIGIN 2020-2030 ($MILLION)
TABLE 2. AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET, BY APPLICATION 2020-2030 ($MILLION)
TABLE 3. AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET, BY END USER 2020-2030 ($MILLION)
TABLE 4.AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET FOR , , 2020-2030 ($MILLION)
TABLE 5.ATLAS BIOLOGICALS: COMPANY SNAPSHOT
TABLE 6.ATLAS BIOLOGICALS: OPERATING SEGMENTS
TABLE 7.BIOLOGICAL INDUSTRIES: COMPANY SNAPSHOT
TABLE 8.BIOLOGICAL INDUSTRIES: OPERATING SEGMENTS
TABLE 9.BIO TECHNE: COMPANY SNAPSHOT
TABLE 10.BIO TECHNE: OPERATING SEGMENTS
TABLE 11.BIOWEST: COMPANY SNAPSHOT
TABLE 12.BIOWEST: OPERATING SEGMENTS
TABLE 13.GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 14.GE HEALTHCARE: OPERATING SEGMENTS
TABLE 15.HIMEDIA LABORATORIES PVT. LTD.: COMPANY SNAPSHOT
TABLE 16.HIMEDIA LABORATORIES PVT. LTD.: OPERATING SEGMENTS
TABLE 17.MERCK KGAA (SIGMA ALDRICH): COMPANY SNAPSHOT
TABLE 18.MERCK KGAA (SIGMA ALDRICH): OPERATING SEGMENTS
TABLE 19.PAN BIOTECH: COMPANY SNAPSHOT
TABLE 20.PAN BIOTECH: OPERATING SEGMENTS
TABLE 21.ROCKY MOUNTAIN BIOLOGICALS: COMPANY SNAPSHOT
TABLE 22.ROCKY MOUNTAIN BIOLOGICALS: OPERATING SEGMENTS
TABLE 23.THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 24.THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS

LIST OF FIGURES
FIGURE 1. AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET SEGMENTATION
FIGURE 2.TOP INVESTMENT POCKET
FIGURE 3.TOP WINNING STRATEGIES (%)
FIGURE 4.AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET FOR AUSTRALIA ORIGIN, 2020-2030 ($MILLION)
FIGURE 5.AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET FOR NEW ZEALAND ORIGIN, 2020-2030 ($MILLION)
FIGURE 6.AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET FOR US ORIGIN, 2020-2030 ($MILLION)
FIGURE 7.AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET FOR MEXICO ORIGIN, 2020-2030 ($MILLION)
FIGURE 8.AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET FOR BRAZIL ORIGIN, 2020-2030 ($MILLION)
FIGURE 9.AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET FOR BIOPHARMACEUTICALS, 2020-2030 ($MILLION)
FIGURE 10.AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET FOR CELL CULTURE, 2020-2030 ($MILLION)
FIGURE 11.AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET FOR HUMAN AND ANIMAL VACCINE PRODUCTION, 2020-2030 ($MILLION)
FIGURE 12.AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET FOR OTHERS, 2020-2030 ($MILLION)
FIGURE 13.AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2020-2030 ($MILLION)
FIGURE 14.AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET FOR ACADEMIC INSTITUTE, 2020-2030 ($MILLION)
FIGURE 15.AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET FOR RESEARCH LABORATORY, 2020-2030 ($MILLION)

 
 

The growth of the market is driven by factors such as increase in funding & investment for R&D activities & innovation in the life science industry, high demand for FBS and rise in advancements associated with biotechnology. In addition, significant rise in the use of sera for cell culture and low supply of the same is anticipated to increase the cost in near future. However, scientific, and ethical concerns associated with biotechnology and dearth of skilled professionals hamper the growth of the market.

In addition, other major factor that drives the growth of FBS market in Australia and New Zealand involve, large cattle herds in these countries. Furthermore, the presence of major key players operating in the FBS market in these countries is another major factor that leads to growth of this market.  

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of Australia and New Zealand fetal bovine serum market is $20 million in 2020.

A. The forecast period for Australia and New Zealand fetal bovine serum market is 2021 to 2030

A. The market value of Australia and New Zealand fetal bovine serum market in 2021 is $22 million.

A. The base year is 2020 in Australia and New Zealand fetal bovine serum market

A. Top companies such as, Thermo Fisher Scientific Inc., GE Healthcare, Merck KGaA, and HiMedia Laboratories Pvt. Ltd, held a high market position in 2020. These key players held a high market postion owing to the strong geographical foothold in Australia and New Zealand.

A. Biotechnology & pharmaceutical company segment is the most influencing segment. This is due to the significant rise in R&D for the development of biopharmaceutical drugs and cancer research which require the use of fetal bovine serum.

A. The major factor that fuels the growth of the Australia and New Zealand fetal bovine serum market includes high demand for fetal bovine sera and surge in biopharmaceutical production.

A. Biotechnology & pharmaceutical company has the highest growth rate in the market with a CAGR of 5.4%.

A. Fetal bovine serum is defined as the liquid fraction that remains after the blood drawn from bovine fetus coagulates.

A. Fetal bovine seum is used in multiple industries for various outcomes. For instance, it is used in biotechnology research and production, vaccine production, animal diagnostics, Stem-cell research and others.

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Australia And New Zealand Fetal Bovine Serum Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers